Follow The Filings

PRCT PROCEPT BioRobotics

PROCEPT BioRobotics earnings company data as of 6:59 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by PRCT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PRCT insider trades
  • $11M bought by 2 insiders
  • None no sales outside a trading plan
  • $222K sold by 1 insider under 10b5-1 plans
  1. Larry L Wood CEO
    Buy
    $498K 23,900 shares at $20.85 New stake
    Traded Aug 7 Filed Aug 10
    ↗
  2. Alaleh Nouri EVP, CLO, Corp. Sec.
    Planned sale
    $139K 5,363 shares at $25.96 4.8% of stake
    Traded Mar 19 Filed Mar 19
    ↗
  3. Alaleh Nouri EVP, CLO, Corp. Sec.
    Planned sale
    $83K 3,243 shares at $25.65 2.8% of stake
    Traded Mar 10 Filed Mar 12
    ↗
  4. Antal Rohit Desai Director
    Buy
    $10.5M 426,262 shares at $24.59 New stake
    Traded Mar 5–9 Filed Mar 9
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 stock grants and 10 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.